The flip side is, that when this commercialization starts, the...

The flip side is, that when this commercialization starts, the growth curve is potentially outstanding.
An existing mams market, who will likely if available on a precautionary principal, want a blood test for early detection. The numbers upside are potentially outstanding. What a market will pay pre revenue, as a stake in what is a bet on the billions growth potentially, in this space.

The buyers and accumulators bet on market discovering this mountain we are setting on. Plenty of pre revenue med trade higher.
The flippers are betting on the cycle of CRs, can occur before the wider market discovers the path this is on.
Pre revenue, there are plenty of buyers to potentially displace the short term flip cycle trade.